Press Releases

2009

> Inimex Announces Appointment of New CEO

   28KB pdf format

> Inimex Pharmaceuticals begins first Clinical Study of an          Innate Defense Regulators
   52KB pdf format

2008
> Inimex Pharmaceuticals Honored Among This Year's Most
   Promising Private Technology Ventures in Canada
   59KB pdf format

> Inimex Raises US $22 Million in the Fight Against Antibiotic
   Resistance
   51KB pdf format

2007
> Inimex Product Candidate is First Immune Defense
   Regulator to Cure Infections Without Causing Harmful
   Inflammation
   22KB pdf format

2006
> Nov 27, 2006
   Inimex Co-Founder Bob Hancock Receives 2006 Michael Smith Prize
   23KB pdf format

> May 16, 2006
   Inimex Invited to Present at C21 Ventures Conference
   25KB pdf format

> March 15, 2006
   Inimex Contributes to Grand Challenges in Global Health (GCGH) Initiative
   25KB pdf format

2005
> November 8, 2005
   Inimex Selected as One of Canada's Top 10 Life Science Investment Prospects
   70KB pdf format

> October 17, 2005
   Inimex Selected to Present at Two San Francisco Venture Financing Conferences
   22KB pdf format

> July 7, 2005:
   Inimex a Key Component of Gates Grand Challenge Award
   29KB pdf format

> June 27, 2005
   Wall Street Reporter Interviews: Inimex President & CEO - John North

> June 15, 2005
   Inimex Achieves Milestone Targets Second Tranche of Series A Financing Released
   100KB pdf format

> June 8, 2005
   Inimex Appoints John North as President and Chief Executive Officer
   40KB pdf format

2004
> December 7, 2004
   Inimex Pharmaceuticals Announces $2 Million Second Closing of Series A
   Venture Capital Financing
   75KB pdf format

> September 20, 2004
   MIT Awards Inimex for Innovation "Predicted to have profound impact on humanity"
   435KB pdf format

> September 20, 2004
   Inimex Founding Scientists Recognized for Scientific Achievement
   108KB pdf format

> July 6, 2004
   Inimex Pharmaceuticals Inc. Announces Series A Venture Capital Financing
   91KB pdf format

2003
> October 14, 2003
   Inimex Pharmaceuticals Appoints Scientific and Medical Advisory Board
   31KB pdf format

> October 7, 2003
   Canada's Top 10 life sciences investment prospects announced for BioNorth 2003
   13KB pdf format

> September 15, 2003
   Inimex Co-Founder Honored at 43rd Interscience Conference on Antimicrobial
   Agents and Chemotherapy (ICAAC)
   29KB pdf format

> May 8, 2003
   Inimex Pharmaceuticals Inc. and Genicon Sciences Corporation to Collaborate
   on Innate Immunity Research
   98KB pdf format

> March 24, 2003
   Inimex Directors Honored at 5th Annual BC Biotechnology Awards Gala
   244KB pdf format

2002
> November 26, 2002
   Inimex Announces Commencement of Genome Canada Project
   87KB pdf format

> September 18, 2002
   Inimex Selected as One of Canada's Top-10 Life Sciences Corporate Investment
   & Partnering Prospects
   151KB pdf format

> April 23, 2002
   Inimex Announces Participation in $27 Million Genome Canada Program
   172KB pdf format

> January 2002
   UBC Patscan News: INIMEX Pharmaceuticals Offers Revolutionary Approach
   to the Antibiotic Crisis